Variant report

Variant	rs10930969
Chromosome Location	chr2:182327957-182327958
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

Extended variants
information (count: 15 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:10)

rs_ID	r²[population]
rs17290693	1.00[ASW][hapmap];1.00[LWK][hapmap];1.00[MKK][hapmap];1.00[YRI][hapmap];0.88[AFR][1000 genomes]
rs2305588	1.00[LWK][hapmap]
rs2305589	1.00[YRI][hapmap];0.88[AFR][1000 genomes]
rs2305590	1.00[YRI][hapmap];0.88[AFR][1000 genomes]
rs3755021	0.92[MKK][hapmap]
rs3770120	1.00[LWK][hapmap]
rs3770124	1.00[YRI][hapmap];0.96[AFR][1000 genomes]
rs3770126	0.82[MKK][hapmap]
rs3770136	1.00[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];0.87[GIH][hapmap];0.94[JPT][hapmap];1.00[LWK][hapmap];1.00[MEX][hapmap];1.00[MKK][hapmap];0.97[TSI][hapmap];0.82[YRI][hapmap];1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs3770138	1.00[ASW][hapmap];1.00[CEU][hapmap];0.92[CHB][hapmap];1.00[CHD][hapmap];0.87[GIH][hapmap];0.89[JPT][hapmap];0.92[LWK][hapmap];0.87[MEX][hapmap];1.00[MKK][hapmap];0.91[TSI][hapmap];1.00[AFR][1000 genomes];0.98[AMR][1000 genomes];0.97[EUR][1000 genomes];0.98[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:5 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1005870	chr2:181968637-182921439	Enhancers Strong transcription Weak transcription Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	39 gene(s)	inside rSNPs	diseases
2	nsv536063	chr2:181968637-182921439	Enhancers Active TSS Weak transcription Strong transcription Bivalent/Poised TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	39 gene(s)	inside rSNPs	diseases
3	nsv1002647	chr2:182078521-182392273	Active TSS Enhancers Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Weak transcription Flanking Active TSS Genic enhancers Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA	7 gene(s)	inside rSNPs	diseases
4	nsv536064	chr2:182078521-182392273	Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Strong transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA	7 gene(s)	inside rSNPs	diseases
5	nsv834476	chr2:182179249-182360259	Strong transcription Flanking Active TSS Active TSS Enhancers Genic enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	6 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:48 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:182322200-182330800	Transcr. at gene 5' and 3'	Dnd41	blood
2	chr2:182323400-182330400	Weak transcription	HMEC	breast
3	chr2:182323400-182332600	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
4	chr2:182323600-182329600	Enhancers	Primary neutrophils fromperipheralblood	blood
5	chr2:182324400-182410400	Weak transcription	NHLF	lung
6	chr2:182324600-182328000	Weak transcription	Duodenum Smooth Muscle	Duodenum
7	chr2:182324600-182330600	Weak transcription	NH-A	brain
8	chr2:182324600-182336400	Weak transcription	Small Intestine	intestine
9	chr2:182324600-182337600	Weak transcription	Sigmoid Colon	Sigmoid Colon
10	chr2:182324600-182340400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
11	chr2:182324600-182360400	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
12	chr2:182324800-182330000	Weak transcription	NHDF-Ad	bronchial
13	chr2:182324800-182330200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
14	chr2:182324800-182330400	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
15	chr2:182325200-182330000	Weak transcription	Muscle Satellite Cultured Cells	--
16	chr2:182325600-182328400	Flanking Active TSS	Primary T cells from cord blood	blood
17	chr2:182326000-182328400	Transcr. at gene 5' and 3'	Primary hematopoietic stem cells short term culture	blood
18	chr2:182326000-182329400	Transcr. at gene 5' and 3'	Fetal Thymus	thymus
19	chr2:182326200-182329200	Weak transcription	Rectal Mucosa Donor 31	rectum
20	chr2:182326200-182337800	Weak transcription	Spleen	Spleen
21	chr2:182326400-182333400	Genic enhancers	Primary B cells from peripheral blood	blood
22	chr2:182326600-182332600	Weak transcription	HSMMtube	muscle
23	chr2:182326800-182328400	Enhancers	Primary T killer memory cells from peripheral blood	blood
24	chr2:182327000-182328000	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood
25	chr2:182327000-182328000	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
26	chr2:182327000-182328800	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
27	chr2:182327000-182329000	Flanking Active TSS	Primary T helper memory cells from peripheral blood 1	blood
28	chr2:182327000-182334000	Enhancers	Primary T killer naive cells fromperipheralblood	blood
29	chr2:182327200-182328000	Enhancers	Rectal Mucosa Donor 29	rectum
30	chr2:182327200-182328200	Enhancers	Duodenum Mucosa	Duodenum
31	chr2:182327200-182328400	Genic enhancers	Primary monocytes fromperipheralblood	blood
32	chr2:182327200-182328800	Flanking Active TSS	Primary hematopoietic stem cells	blood
33	chr2:182327200-182329600	Transcr. at gene 5' and 3'	GM12878-XiMat	blood
34	chr2:182327200-182330400	Enhancers	Primary T regulatory cells fromperipheralblood	blood
35	chr2:182327200-182333400	Genic enhancers	Primary B cells from cord blood	blood
36	chr2:182327400-182329000	Transcr. at gene 5' and 3'	Primary T cells fromperipheralblood	blood
37	chr2:182327400-182330000	Transcr. at gene 5' and 3'	Primary hematopoietic stem cells G-CSF-mobilized Male	--
38	chr2:182327400-182334000	Enhancers	Primary T helper naive cells fromperipheralblood	blood
39	chr2:182327600-182328000	Enhancers	Monocytes-CD14+_RO01746	blood
40	chr2:182327600-182328800	Transcr. at gene 5' and 3'	Primary hematopoietic stem cells G-CSF-mobilized Female	--
41	chr2:182327600-182329400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
42	chr2:182327800-182328200	Enhancers	Primary T helper naive cells from peripheral blood	blood
43	chr2:182327800-182328400	Flanking Active TSS	Primary T helper memory cells from peripheral blood 2	blood
44	chr2:182327800-182328800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
45	chr2:182327800-182329000	Flanking Active TSS	Primary T helper 17 cells PMA-I stimulated	--
46	chr2:182327800-182329000	Flanking Active TSS	Thymus	Thymus
47	chr2:182327800-182329800	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
48	chr2:182327800-182330800	Strong transcription	Primary Natural Killer cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links